- Home
- MTR vs MYNZ Comparison
MTR vs MYNZ Comparison
Compare MTR & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTR
- MYNZ
- Stock Information
- Founded
- MTR 1979
- MYNZ 2021
- Country
- MTR United States
- MYNZ Germany
- Employees
- MTR N/A
- MYNZ N/A
- Industry
- MTR Oil & Gas Production
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- MTR Energy
- MYNZ Health Care
- Exchange
- MTR Nasdaq
- MYNZ Nasdaq
- Market Cap
- MTR 9.5M
- MYNZ 7.9M
- IPO Year
- MTR N/A
- MYNZ 2021
- Fundamental
- Price
- MTR $4.68
- MYNZ $1.46
- Analyst Decision
- MTR
- MYNZ Buy
- Analyst Count
- MTR 0
- MYNZ 2
- Target Price
- MTR N/A
- MYNZ $14.00
- AVG Volume (30 Days)
- MTR 13.3K
- MYNZ 542.5K
- Earning Date
- MTR 01-01-0001
- MYNZ 12-29-2025
- Dividend Yield
- MTR 4.49%
- MYNZ N/A
- EPS Growth
- MTR N/A
- MYNZ N/A
- EPS
- MTR 0.21
- MYNZ N/A
- Revenue
- MTR $580,337.00
- MYNZ $659,935.00
- Revenue This Year
- MTR N/A
- MYNZ $26.06
- Revenue Next Year
- MTR N/A
- MYNZ $4.97
- P/E Ratio
- MTR $22.46
- MYNZ N/A
- Revenue Growth
- MTR N/A
- MYNZ N/A
- 52 Week Low
- MTR $4.68
- MYNZ $1.28
- 52 Week High
- MTR $10.42
- MYNZ $14.39
- Technical
- Relative Strength Index (RSI)
- MTR 31.50
- MYNZ 42.18
- Support Level
- MTR $4.72
- MYNZ $1.51
- Resistance Level
- MTR $5.34
- MYNZ $1.63
- Average True Range (ATR)
- MTR 0.13
- MYNZ 0.12
- MACD
- MTR -0.02
- MYNZ 0.00
- Stochastic Oscillator
- MTR 0.00
- MYNZ 29.03
About MTR Mesa Royalty Trust
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.